Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Carcinoma, Squamous Cell × Surgical Procedures, Operative × Clear all

Phase

Phase 2 3 Phase 3 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 3 Stomach Neoplasms 2 Colorectal Neoplasms 2 Skin Neoplasms 1 Radiation Injuries 1 Postoperative Complications 1 Pilonidal Sinus 1 Neoplasms 1 Low Anterior Resection Syndrome 1 Gestational Trophoblastic Disease 1 Fatigue 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

ponatinib 1 pembrolizumab 1 Surgical Procedures, Operative 1 Gemcitabine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06295809 2025-12-09

INTerpath-007

Merck Sharp & Dohme LLC

Phase 2/3 Active not recruiting

Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡